Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-17-Speech-3-105"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-12-17"^^xsd:date2
dcterms:Is Part Of	lp_eu:Vote2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20031217.4.3-105"2
lpv:hasSubsequent	lp_eu:2003-12-17-Speech-3-1062
lpv:speaker	lp:Jules Maaten2
lpv:spokenAs	unknown; Volkspartij voor Vrijheid en Democratie (1999-07-20--2004-07-19)3 member_of_the_bureau; ELDR (2002-03-07--2004-07-19)3 member; Delegation for relations with the Member States of ASEAN, south-east Asia and the Republic of Korea (2002-02-07--2004-07-19)3 substitute; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (2002-01-17--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3
lpv:translated text	". The compromise is a step forward for the competitiveness of the pharmaceutical industry, the knowledge-based economy and the availability of medicinal products in the EU. Dossier protection for pharmaceutical products in the EU varies from six to ten years. The result is that the supply and price of medicinal products varies considerably among the Member States. The ‘8 + 2 + 1’ compromise involves eight years’ dossier protection, plus two years for generic medicinal products, to put the dossier in order, followed by market access, and then one year’s extra protection for the innovative industry if a medicinal product also has a therapeutic effect for other illnesses; and results in greater price competition, an improved supply of medicinal products and a boost to the knowledge-based economy. The Council has failed by omitting to include homeopathic medicinal products in the compromise package. As a result, these medicinal products remain a legal grey area, and homeopathic medicinal products will continue to circulate illegally on the market. I therefore call on the European Commission to present a proposal as quickly as possible regulating the registration of homeopathic medicinal products at European level; only then will the European market in medicinal products be complete. Homeopathic medicinal products represent an important alternative for many people. I, too, rank among those who have a great deal of confidence in the therapeutic effects of these medicinal products."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph